{"id":76,"date":"2015-02-12T11:24:03","date_gmt":"2015-02-12T10:24:03","guid":{"rendered":"http:\/\/candidati.unica.it\/mariadelzompo\/?page_id=76"},"modified":"2016-09-27T14:41:49","modified_gmt":"2016-09-27T12:41:49","slug":"pubblicazioni-internazionali","status":"publish","type":"page","link":"https:\/\/candidati.unica.it\/mariadelzompo\/profilo\/pubblicazioni-internazionali\/","title":{"rendered":"Pubblicazioni internazionali"},"content":{"rendered":"<ul>\n<li>Viswanath\u00a0B et al. Cellular models to study bipolar disorder: A systematic review.<em> J Affect Disord.<\/em> 2015;\u00a0184:36-50 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26070045\">abs<\/a>]<\/li>\n<li>Costa M et al.\u00a0Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes.<em>\u00a0<span class=\"jrnl\" title=\"Journal of molecular neuroscience : MN\">J Mol Neurosci<\/span><\/em>. 2015;\u00a056:688-95 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25912293\">abs<\/a>]<\/li>\n<li>Cadeddu G et al. \u00a0Clozapine toxicity due to a multiple drug interaction: a case report.\u00a0\u00a0<em><span class=\"jrnl\" title=\"Journal of medical case reports\">J Med Case Rep<\/span>.<\/em> 2015 9:77 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25890012\">abs<\/a>]<\/li>\n<li>Bauer M et al.\u00a0Influence of light exposure during early life on the age of onset of bipolar disorder.<em>\u00a0J Psychiatr Res.<\/em> 2015; 64:1-8 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25862378\">abs<\/a>]<\/li>\n<li>Milanesi E et al. Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients.\u00a0<em><span class=\"jrnl\" title=\"Journal of molecular neuroscience : MN\">J Mol Neurosci<\/span>.<\/em> 2015 Mar 5. [Epub ahead of print] [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25740013\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. <em>BMC Medicine<\/em> 2015; 13:12 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25604586\">abs<\/a>]<\/li>\n<li>Hunsberger JG et al. \u00a0Novel integrative genomic tool for interrogating lithium response in bipolar disorder. <em>Translational Psychiatry<\/em> 2015; 5: e504 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25646593\">abs<\/a>]<\/li>\n<li>International Genomics of Alzheimer&#8217;s Disease Consortium (IGAP). Convergent genetic and expression data implicate immunity in Alzheimer&#8217;s disease. <em>Alzheimer&#8217;s and Dementia<\/em> 2014 Dec 20. pii: S1552-5260(14)02492-3. [Epub ahead of print] [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25533204\">abs<\/a>]<\/li>\n<li>Bauer M et al.\u00a0Influence of birth cohort on age of onset cluster analysis in bipolar I disorder. <em>European Psychiatry<\/em> 2015; 30: 99-105 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25498240\">abs<\/a>]<\/li>\n<li>Niola P et al. Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene. <em>Psychiatry Research<\/em> 2014; 220: 1167-1168.<\/li>\n<li>Bauer M et al. Relationship between sunlight and the age of onset of bipolar disorder: an international multisite study.\u00a0<em>J Affect Disord<\/em>\u00a0167: 104-11, 2014. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24953482\">abs<\/a>]<\/li>\n<li>Escott-Price V et al. Gene-wide analysis detects two new susceptibility genes for Alzheimer&#8217;s disease.\u00a0<em>PLoS One<\/em>\u00a09: e94661, 2014. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24922517\">abs<\/a>]<\/li>\n<li>Floris G et al. \u00a0C9ORF72 repeat expansion and bipolar disorder &#8211; is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder.\u00a0<em>Bipolar Disorders<\/em>\u00a016: 667-8, 2014.<\/li>\n<li>Del Zompo M et al. Association study in three different populations between the GPR88 gene and major psychoses.\u00a0<em>Mol Genet Genomic Med<\/em>\u00a02: 152-9, 2014. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24689078\">abs<\/a>]<\/li>\n<li>Deiana V et al. Continuation versus discontinuation of lithium during pregnancy: a retrospective case series.\u00a0<em>J Clin Psychopharmacol<\/em>\u00a034: 407-10, 2014.<\/li>\n<li>Lambert JC et al. \u00a0Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#8217;s disease.\u00a0<em>Nature Genetics<\/em>\u00a045: 1452-8, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24162737\">abs<\/a>]<\/li>\n<li>Pisanu C et al. No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample&#8221;.\u00a0<em>Psychiatry Res<\/em>\u00a0210: 887-90, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24126189\">abs<\/a>]<\/li>\n<li>Manchia M et al. \u00a0Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report.\u00a0<em>PLoS One<\/em>\u00a08: e65636, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23840348\">abs<\/a>]<\/li>\n<li>Squassina A et al. Differential effect of lithium on spermidine\/spermine N1-acetyltransferase expression in suicidal behaviour.\u00a0<em>Int J Neuropsychopharmacol<\/em>\u00a016: 2209-18, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23768751\">abs<\/a>]<\/li>\n<li>Manchia M et al. Genetic risk of suicidal behavior in bipolar spectrum disorder: analysis of 737 pedigrees.\u00a0<em>Bipolar Disorders<\/em>\u00a015: 496-506, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23734877\">abs<\/a>]<\/li>\n<li>Squassina A et al. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.\u00a0<em>Pharmacol Res\u00a0<\/em>73: 1-7, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23619527\">abs<\/a>]<\/li>\n<li>Severino G et al. Pharmacogenomics of bipolar disorder.\u00a0<em>Pharmacogenomics<\/em>\u00a014: 655-674, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23570469\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study.\u00a0<em>BMC Medicine<\/em>\u00a011: 33, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23399351\">abs<\/a>]<\/li>\n<li>Costa M et al. Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-\u03b1 gene (PPARA) and schizophrenia.\u00a0<em>European Neuropsychopharmacology<\/em>\u00a023: 749-59, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22920733\">abs<\/a>]<\/li>\n<li>Lambert JC et al. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer&#8217;s disease.\u00a0<em>Mol Psychiatry<\/em>\u00a018: 461-470, 2013. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22430674\">abs<\/a>]<\/li>\n<li>Stochino ME et al. Evaluation of lithium response in episodic cluster headache: a retrospective case series.\u00a0<em>Headache<\/em>\u00a052: 1171-1175, 2012. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22670710\">abs<\/a>]<\/li>\n<li>Bauer M et al. \u00a0Impact of sunlight on the age of onset of bipolar disorder.\u00a0<em>Bipolar Disorders<\/em>\u00a014: 654-663, 2012. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22612720\">abs<\/a>]<\/li>\n<li>Squassina A et al. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.\u00a0<em>Pharmacogenomics\u00a0<\/em>12: 1559-1569, 2011. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21961650\">abs<\/a>]<\/li>\n<li>Deiana V et al. A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness.\u00a0<em>J Clin Psychopharmacol<\/em>\u00a031: 538-540, 2011.<\/li>\n<li>Genin E et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance.\u00a0<em>Molecular Psychiatry<\/em>\u00a016: 903-907, 2011. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21556001\">abs<\/a>]<\/li>\n<li>Squassina A. et al. Age at onset in bipolar disorder: Investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample.\u00a0<em>European Psychiatry<\/em>\u00a026: 141-143, 2011. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21292452\">abs<\/a>]<\/li>\n<li>Lambert JC et al. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations.\u00a0<em>Neurobiol Aging<\/em>\u00a032: 756.e11-5, 2011. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21220176\">abs<\/a>]<\/li>\n<li>Tozzi F et al. Admixture analysis of age at onset in bipolar disorder.\u00a0<em>Psychiatry Research<\/em>\u00a0185: 27-32, 2011. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20580841\">abs<\/a>]<\/li>\n<li>Squassina A, Manchia M, Del Zompo M. Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.\u00a0<em>Human Genomics and Proteomics<\/em>,\u00a0159761, 2010. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20981231\">abs<\/a>]<\/li>\n<li>Lambert JC et al. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer&#8217;s disease: a meta-analysis study.\u00a0<em>Journal of Alzheimers Disease<\/em>\u00a022: 247-255, 2010. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20847397\">abs<\/a>]<\/li>\n<li>Squassina A et al. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.\u00a0<em>Pharmacogenomics\u00a0<\/em>11: 1149-1167, 2010. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20712531\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21?.\u00a0<em>Am J Med Genet B Neuropsychiatr Genet<\/em>\u00a0153B: 1200-1208, 2010. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20468074\">abs<\/a>]<\/li>\n<li>Schulze TG et al. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.\u00a0<em>Neuropsychobiology\u00a0<\/em>62: 72-78, 2010. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20453537\">abs<\/a>]<\/li>\n<li>Asuni C et al. Mixture analysis of age at onset in migraine without aura: evidence for three subgroups.\u00a0<em>Headache<\/em>\u00a050: 1313-1319, 2010. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20408885\">abs<\/a>]<\/li>\n<li>Squassina A et al. NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample.\u00a0<em>Psychiatry Research<\/em>\u00a0176: 82-84, 2010. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20061032\">abs<\/a>]<\/li>\n<li>Manchia M et al. Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients.\u00a0<em>Neuroscience Letters<\/em>\u00a0467: 67-71, 2009. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19818381\">abs<\/a>]<\/li>\n<li>Manchia M et al. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.<em>\u00a0<\/em><em>Psychiatry Research<\/em>\u00a0169: 164-166, 2009. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19647327\">abs<\/a>]<\/li>\n<li>Asuni C et al. Migraine and tumour necrosis factor gene polymorphism. An association study in a Sardinian sample.\u00a0<em>Journal of Neurology<\/em>\u00a0256: 194-197, 2009. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19253056\">abs<\/a>]<\/li>\n<li>Squassina A et al. The diacylglycerol kinase eta (DGKH) gene and bipolar disorder: a replication study in a Sardinian sample.\u00a0<em><span style=\"text-decoration: underline;\">Molecular Psychiatry<\/span><\/em>\u00a014: 350-351, 2009.<\/li>\n<li>Severino G et al. Association study in a Sardinian sample between Bipolar Disorder and the nuclear receptor REV-ERB\u03b1 gene, a critical component of the circadian clock system.\u00a0<em><span style=\"text-decoration: underline;\">Bipolar Disorders<\/span><\/em>\u00a011: 215-220, 2009. [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19267705\">abs<\/a>]<\/li>\n<li>Squassina A. et al. A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample.\u00a0<em><span style=\"text-decoration: underline;\">Psychiatric Genetics<\/span><\/em>\u00a018: 128-132, 2008 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18496210?ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Squassina A et al. The PDLIM5 gene and lithium prophylaxis: An association and gene expression analysis in Sardinian patients with bipolar disorder.\u00a0<em><span style=\"text-decoration: underline;\">Pharmacological Research<\/span><\/em>\u00a057: 369-73, 2008 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18456508?ordinalpos=2&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Manchia M et al. Age at onset in Sardinian bipolar I patients: evidence for three subgroups.\u00a0<em><span style=\"text-decoration: underline;\">Bipolar Disorders<\/span><\/em>\u00a010: 443-446, 2008 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18402633?ordinalpos=3&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Long term lithium treatment and survival from external causes including suicide.\u00a0<em><span style=\"text-decoration: underline;\">J Clin Psychopharmacol<\/span><\/em>\u00a0\u00a027: 544-546, 2007 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17873708?ordinalpos=4&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Piccardi MP et al. Alzheimer\u2019s disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.\u00a0<em><span style=\"text-decoration: underline;\">American Journal of Medical Genetics Part B (Neuropsychiatric Genetics)<\/span><\/em>\u00a0144: 895-899, 2007 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17503475?ordinalpos=7&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Asuni C et al. Association study between clinical response to rizatriptan and some candidate genes.\u00a0<em><span style=\"text-decoration: underline;\">J Headache Pain<\/span><\/em>\u00a08: 185-9, 2007 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17563839?ordinalpos=6&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Fifteen-year follow-up of thyroid function in lithium patients\u201d.\u00a0<em><span style=\"text-decoration: underline;\">J Endocrinol Invest<\/span><\/em>\u00a030: 363-366, 2007 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17598966?ordinalpos=5&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia\u201d.\u00a0<em><span style=\"text-decoration: underline;\">American Journal of Medical Genetics Part B (Neuropsychiatric Genetics)<\/span><\/em>\u00a0144B: 237-241, 2007 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17066478?ordinalpos=8&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Ghiani ME et al. Genetic, demographic and archival study on a Sardinian village. In:\u00a0<a href=\"http:\/\/www.ressign.com\/UserBookDetail.aspx?bkid=387&amp;catid=140\">Human Genetic Isolates<\/a>, eds. C. Cal\u00f2 and G. Vona, Research Signpost, Kerala (India); pp. 131-149, 2006.<\/li>\n<li>Galderisi S et al. COMT VAL158Met and BDNF C270T polymorphisms in schizophrenia: associations with cognitive and motor impairment.\u00a0<em><span style=\"text-decoration: underline;\">Neuropsychobiology<\/span><\/em>\u00a052: 83-89, 2005 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16037677?ordinalpos=9&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Severino G et al. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder.\u00a0<em><span style=\"text-decoration: underline;\">American Journal of Medical Genetics (Neuropsychiatric Genetics)<\/span><\/em>\u00a0134B: 37-38, 2005 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15704231?ordinalpos=10&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Galderisi S et al. COMT VAL158Met and BDNF C270T polymorphisms in schizophrenia: a case-control study.\u00a0<em><span style=\"text-decoration: underline;\">Schizophrenia Research<\/span><\/em>\u00a073: 27-30, 2005 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15567073?ordinalpos=11&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Severino G et al. Adverse drug reactions during imatinib and lansoprazole treatment in GIST.\u00a0<em><span style=\"text-decoration: underline;\">The Annals of Pharmacotherapy<\/span><\/em>\u00a039: 162-164, 2005 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15546944?ordinalpos=12&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Severino G, Del Zompo M. Adverse drug reactions: role of pharmacogenomics.\u00a0<em><span style=\"text-decoration: underline;\">Pharmacological Research<\/span><\/em>\u00a049: 363-373, 2004 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15202516?ordinalpos=13&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Cousin E et al. Association studies in candidate genes: strategies to select SNPs to be tested.\u00a0<em><span style=\"text-decoration: underline;\">Human Heredity<\/span><\/em>\u00a056: 151-159, 2003.<\/li>\n<li>Stochino ME et al. Association study between the phenotype migraine without aura \u2013 panic disorder and dopaminergic receptor genes.\u00a0<em><span style=\"text-decoration: underline;\">Pharmacological Research<\/span><\/em>\u00a048: 531-534, 2003 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12967601?ordinalpos=15&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Severino G et al. Pharmacogenomics: state of the research and perspectives in clinical application.\u00a0<em><span style=\"text-decoration: underline;\">Neurological Sciences<\/span><\/em>\u00a024 (Suppl. 2): S146-8, 2003 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12811615?ordinalpos=16&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Piccardi MP et al. Manic-depressive illness: association study with the inositol polyphosphate 1-phosphatase and serotonin transporter genes.\u00a0<em><span style=\"text-decoration: underline;\">Psychiatric Genetics<\/span><\/em>\u00a012:23-27, 2002 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11901356?ordinalpos=17&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Cherchi A, Del Zompo M. &#8220;Pharmacology\u201d.\u00a0In:\u00a0<a href=\"http:\/\/books.google.it\/books?id=1MrXU8PRuCMC\">Headache and Migraine in Childhood and Adolescence<\/a>, eds. V. Guidetti, G. Russell, M. Sillanpaa, P. Winner, Martin Dunitz, London, pp. 37-47, 2002.<\/li>\n<li>Zuddas A, Del Zompo M. &#8220;Neurochemistry\u201d.\u00a0In:\u00a0<a href=\"http:\/\/books.google.it\/books?id=1MrXU8PRuCMC\">Headache and Migraine in Childhood and Adolescence<\/a>, eds. V. Guidetti, G. Russell, M. Sillanpaa, P. Winner, Martin Dunitz, London, pp. 19-36, 2002.<\/li>\n<li>Bocchetta A et al. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients.\u00a0<em><span style=\"text-decoration: underline;\">Acta Psychiatrica Scandinavica<\/span><\/em>\u00a0104: 37-41, 2001 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11437748?ordinalpos=18&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Cherchi A et al. Role of dopaminergic system in migraine.\u00a0<em><span style=\"text-decoration: underline;\">Journal of Headache and Pain<\/span><\/em>\u00a02:S47-S49, 2001.<\/li>\n<li>Paoletti AM et al. Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause.\u00a0<em><span style=\"text-decoration: underline;\">The Journal of Clinical Endocrinology &amp; Metabolism<\/span><\/em>\u00a086, 608-612, 2001.<\/li>\n<li>Del Zompo M. Dopaminergic hypersensitivity in migraine: Clinical and genetic evidence.\u00a0<em><span style=\"text-decoration: underline;\">Functional Neurology<\/span><\/em>\u00a015 (Suppl. 3): 163-170, 2000 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11200787?ordinalpos=19&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Cherchi A et al. Positive association between dopamine D2 receptor gene and migraine without aura in a Sardinian sample. In: Frontiers in Headache Research vol. 8, \u201cThe Genetic of Headache Disorders\u201d, eds. J. Olesen and M-G. Bousser, Lippincott Williams &amp; Wilkins, Philadelphia, pp. 211-215, 2000.<\/li>\n<li>Bocchetta A et al. Family-based association study between bipolar disorder and DRD2, DRD4 and SERT in Sardinia.\u00a0<em><span style=\"text-decoration: underline;\">American Journal of Medical Genetics (Neuropsychiatric Genetics)<\/span><\/em>, 88, 522-526, 1999 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10490710?ordinalpos=20&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in Sardinia\u201d. Psychiatric Genetics 9, 63-68, 1999 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10412184?ordinalpos=21&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Morelli M et al. Induction of fos-like immunoreactivity in the central extended amygdala by antidepressant drugs\u201d.\u00a0<em><span style=\"text-decoration: underline;\">Synapse<\/span><\/em>\u00a031, 1-4, 1999 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10025677?ordinalpos=23&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample.\u00a0<em><span style=\"text-decoration: underline;\">Neurology<\/span><\/em>\u00a051, 781-786, 1998 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9748026?ordinalpos=25&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts.\u00a0<em><span style=\"text-decoration: underline;\">Journal of Clinical Psychopharmacology<\/span><\/em>\u00a018, 384-389, 1998 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9790156?ordinalpos=24&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Lai M et al. Therapy of migraine by modulating dopamine hypersensitivity: its effect on mood and pain.\u00a0<em><span style=\"text-decoration: underline;\">International Journal of Clinical Pharmacological Research<\/span><\/em>\u00a017, 101-103, 1997 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9403364?ordinalpos=28&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Piccardi MP et al. No evidence of association between dopamine D3 receptor gene and bipolar affective disorder.\u00a0<em><span style=\"text-decoration: underline;\">American Journal of Medical Genetics (Neuropsychiatric Genetics)<\/span><\/em>\u00a074, 137-139, 1997 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9129711?ordinalpos=26&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Carbamazepine augmentation in lithium refractory bipolar patients: a prospective study on long-term prophylactic effectiveness.\u00a0<em><span style=\"text-decoration: underline;\">Journal of Clinical Psychopharmacology<\/span><\/em>\u00a017, 92-96, 1997 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10950470?ordinalpos=27&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Ruiu S et al. Heterogeneity of monoaminergic vesicular carriers: pharmacological evidence using MPP+ as a marker.\u00a0<em><span style=\"text-decoration: underline;\">Life Sciences<\/span><\/em>\u00a059, 1703-1710, 1996 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8890944?ordinalpos=32&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Loi V et al. Sumatriptan and panic-like symptoms.\u00a0\u00a0<em><span style=\"text-decoration: underline;\">American Journal of Psychiatry<\/span><\/em>\u00a0153: 1505, 1996 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8890694?ordinalpos=30&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Six-year follow-up of thyroid function during lithium treatment.\u00a0<em><span style=\"text-decoration: underline;\">Acta Psychiatrica Scandinavica<\/span><\/em>\u00a094, 45-48, 1996 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8841676?ordinalpos=31&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Dopamine hypersensitivity in migraine: role in apomorphine syncope.\u00a0<em><span style=\"text-decoration: underline;\">Headache<\/span><\/em>\u00a035, 222-224, 1995 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7775179?ordinalpos=33&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Thyroid function during carbamazepine.\u00a0<em><span style=\"text-decoration: underline;\">Biological Psychiatry<\/span><\/em>\u00a036, 135-136, 1994 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7948446?ordinalpos=34&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A, Piccardi MP, Del Zompo M. Is bipolar disorder linked to Xq28?\u00a0<em><span style=\"text-decoration: underline;\">Nature Genetics<\/span><\/em>\u00a06, 224, 1994 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8012380?ordinalpos=35&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. A double-blind study of l-sulpiride versus amitriptyline in lithium-maintained bipolar depressives.\u00a0<em><span style=\"text-decoration: underline;\">Acta Psychiatrica Scandinavica<\/span><\/em>\u00a088, 434-439, 1993 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8310852?ordinalpos=37&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Martinelli V et al. An interaction between carbamazepine and fluvoxamine.\u00a0<em><span style=\"text-decoration: underline;\">British Journal of Clinical Pharmacology<\/span><\/em>\u00a036, 615-616, 1993 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12959283?ordinalpos=36&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Genetic linkage and association studies in affective disorders.\u00a0In:\u00a0<a href=\"http:\/\/www.abebooks.co.uk\/servlet\/BookDetailsPL?bi=1203485723&amp;searchurl=ds%3D30%26isbn%3D9780781700030%26n%3D100121501%26sortby%3D15\">Psychiatry and Advanced Technologies<\/a>, Eds. L. Ravizza, F. Bogetto, E. Zanalda, Raven Press Ltd., New York, pp. 283-287, 1993.<\/li>\n<li>Del Zompo M et al. Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.\u00a0<em><span style=\"text-decoration: underline;\">British Journal of Pharmacology<\/span><\/em>\u00a0109, 411-414, 1993 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8102929?ordinalpos=38&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Vaccari A et al. Differential interaction of 1-methyl-4-phenylpyridinium ion with the putatively vesicular binding site of [3H]tyramine in dopaminergic and nondopaminergic brain regions.\u00a0<em><span style=\"text-decoration: underline;\">Journal of Neurochemistry<\/span><\/em>\u00a060, 758-760, 1993 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8419550?ordinalpos=39&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study.\u00a0<em><span style=\"text-decoration: underline;\">Acta Psychiatrica Scandinavica<\/span><\/em>\u00a086, 38-41, 1992 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1414397?ordinalpos=40&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Localization of MPP+ binding sites in the brain of various mammalian species.\u00a0<em><span style=\"text-decoration: underline;\">Journal of Neural Transmission<\/span><\/em>\u00a0[P-D Sect] 4, 181-190, 1992 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1627253?ordinalpos=43&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M. Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes.\u00a0<em><span style=\"text-decoration: underline;\">Brain Research<\/span><\/em>\u00a0571, 354-357, 1992 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1611504?ordinalpos=42&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Association and linkage studies of affective disorders.\u00a0In: \u201cBiological Psychiatry\u201d vol. 2, Eds. G. Racagni, N. Brunello, T. Fukuda, Elsevier Sci. Publ., pp. 446-448, 1991.<\/li>\n<li>Del Zompo M et al. A double-blind study of minaprine versus amitriptyline in major depression.\u00a0<em><span style=\"text-decoration: underline;\">Neuropsychobiology<\/span><\/em>\u00a024, 79-83, 1991.<\/li>\n<li>Gessa GL et al. \u00a0SCH 23390 and psychosis.\u00a0<em><span style=\"text-decoration: underline;\">The Lancet<\/span><\/em>\u00a0338, 185-186, 1991.<\/li>\n<li>Del Zompo M et al. High-affinity binding of [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular location.\u00a0<em><span style=\"text-decoration: underline;\">European Journal of Pharmacology<\/span><\/em>\u00a0202, 293-294, 1991.<\/li>\n<li>Burrai C, Bocchetta A, Del Zompo M. Mania and fluvoxamine.\u00a0\u00a0<em><span style=\"text-decoration: underline;\">American Journal of\u00a0 Psychiatry<\/span><\/em>\u00a048, 263-1264, 1991.<\/li>\n<li>Gessa GL et al. Lack of acute antispychotic effect of SCH 23390, a selective dopamine D1 receptor antagonists.\u00a0<em><span style=\"text-decoration: underline;\">The Lancet<\/span><\/em>\u00a0337, 854-855, 1991.<\/li>\n<li>Bocchetta A et al. Thyroid abnormalities during lithium treatment.\u00a0\u00a0<em><span style=\"text-decoration: underline;\">Acta Psychiatrica Scandinavica<\/span><\/em>\u00a083, 193-198, 1991 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1903238?ordinalpos=48&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A et al. Familial rates of affective illness in Sardinia with special reference to schizoaffective disorder.\u00a0<em><span style=\"text-decoration: underline;\">European Archives of Psychiatry and Clinical Neuroscience<\/span><\/em>\u00a0240, 16-20, 1990 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2147897?ordinalpos=52&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Bocchetta A, Del Zompo M. Bipolar affective disorder and heterozygous beta-thalassaemia.\u00a0\u00a0<em><span style=\"text-decoration: underline;\">American Journal\u00a0 of Psychiatry<\/span><\/em>\u00a0147, 1094, 1990.<\/li>\n<li>Bernardi F, Del Zompo M. Clozapine in idiopathic Parkinson&#8217;s disease.\u00a0<em><span style=\"text-decoration: underline;\">Neurology<\/span><\/em>\u00a0 40, 1151-1152, 1990.<\/li>\n<li>Del Zompo M. 3H-MPP+ binding sites in mouse brain: pharmacological and biological characterization.\u00a0<em><span style=\"text-decoration: underline;\">Journal of Neurochemistry<\/span><\/em>\u00a054, 1905-1910, 1990 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2338548?ordinalpos=51&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>].<\/li>\n<li>Del Zompo M. Pharmacological characterization of 3H-MPP+ binding sites. In: \u201cAging Brain and Dementia: New Trends in Diagnosis and Therapy\u201d, Eds.\u00a0 L. Battistin, F. Gerstenbrand, Alan R. Liss, New York, pp. 273-280, 1990.<\/li>\n<li>Del Zompo M et al. Clinical evidence for a role of dopaminergic system in depressive syndromes.\u00a0\u00a0In: \u201cDopamine and Mental Depression\u201d, Advances in the Biosciences vol. 77,\u00a0 Eds.\u00a0\u00a0G.L. Gessa, G. Serra, Pergamon Press, pp. 177-184, 1990.<\/li>\n<li>Del Zompo M et al. Genetic markers in affective disorders in Sardinia. In: \u201cThe Modes of Depression: Psychobiology and Psychodynamics\u201d, eds. L. Ravizza, E. Genazzani, R. Torta, C. Eva, Edizioni Libraria Cortina, Torino, pp. 143-149, 1989.<\/li>\n<li>Ruiu S et al. Correspondence between 3H-MPP+ binding site and MAO-A enzyme: pharmacological evidences.\u00a0<em><span style=\"text-decoration: underline;\">Pharmacological Research<\/span><\/em>\u00a021 (Suppl. 1): 15-16, 1989.<\/li>\n<li>Marongiu ME et al. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies.\u00a0<em><span style=\"text-decoration: underline;\">Neuroscience Letters<\/span><\/em>\u00a094, 349-354, 1988 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3264604?ordinalpos=3&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corsini GU et al. Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivo.\u00a0\u00a0<em><span style=\"text-decoration: underline;\">Biochemical Pharmacology<\/span><\/em>\u00a037, 4163-4169, 1988 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3263863?ordinalpos=57&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corongiu FP et al. MPTP fails to induce lipid peroxidation in vivo.\u00a0<em><span style=\"text-decoration: underline;\">Biochemical Pharmacology<\/span><\/em>\u00a035, 2251-2253, 1987 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3496886?ordinalpos=58&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corsini GU et al. Characterization of\u00a0 [3H]MPTP binding sites. In: \u201cParkinson\u2019s disease\u201d, Advances in Neurology vol. 45, Eds. M.S. Yahr and K.J. Bergmann, , Raven Press, New York, pp. 153-158, 1987.<\/li>\n<li>Del Zompo M et al. Properties of\u00a0 3H-MPTP binding sites in human blood platelets.\u00a0<em><span style=\"text-decoration: underline;\">Life Sciences<\/span><\/em>\u00a039, 1885-1892, 1986 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3490614?ordinalpos=60&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. High affinity binding sites for l-methyl-4-phenyl-pyridinium ion (MPP+) are present in mouse brain.\u00a0<em><span style=\"text-decoration: underline;\">European Journal of Pharmacology<\/span><\/em>\u00a0129, 87-92, 1986 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3490391?ordinalpos=61&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corsini GU et al. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.\u00a0\u00a0<em><span style=\"text-decoration: underline;\">Journal of Pharmacology and Experimental Therapeutics<\/span><\/em>\u00a0238, 648-652, 1986 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3488394?ordinalpos=62&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corsini GU et al. In vitro MAO type B dependent formation of an alkylating metabolite from 3H-MPTP in rat and monkey brain. In: \u201cMPTP: a neurotoxin producing a parkinsonian syndrome\u201d, eds.\u00a0 S.P. Markey, M. Castagnoli Jr, A.J. Trevor, I.J. Kopin, Academic Press, New York, pp. 371-376, 1986.<\/li>\n<li>Corsini GU et al. Primate-rodent 3H-MPTP binding differences and biotrasformation of MPTP to a reactive intermediate in vitro.\u00a0<em><span style=\"text-decoration: underline;\">Journal of Neural Transmission<\/span><\/em>\u00a0 22 (Suppl.), 55-60, 1986 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3097260?ordinalpos=65&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies.\u00a0<em><span style=\"text-decoration: underline;\">Brain Research<\/span><\/em>\u00a0378, 320-324, 1986 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3089539?ordinalpos=63&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Dopamine agonists in the treatment of schizophrenia.\u00a0\u00a0In: \u201cProgress in Brain Research\u201d vol. 65, Eds.\u00a0 J.M. Van Ree and S. Matthysse, Elsevier Publishers B.V., pp. 41-48, 1986.<\/li>\n<li>Bocchetta A et al. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro.\u00a0<em><span style=\"text-decoration: underline;\">Journal of Neurochemistry<\/span><\/em>\u00a045, 673-676, 1985 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3928808?ordinalpos=66&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corsini GU et al. Therapeutic efficacy of a partial dopamine agonist in drug-free Parkinsonian patients.\u00a0\u00a0<em><span style=\"text-decoration: underline;\">Journal of Neural Transmission<\/span><\/em>\u00a064, 105-111, 1985 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4078566?ordinalpos=69&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Deprenyl selectively inhibits [3H]MPTP binding sites in monkey brain.\u00a0<em><span style=\"text-decoration: underline;\">European Journal of Pharmacology<\/span><\/em>\u00a0107, 285-286, 1985.<\/li>\n<li>Del Zompo M et al. Inhibition of 3H-MPTP binding to rat brain by pargyline.\u00a0<em><span style=\"text-decoration: underline;\">Biochemical Pharmacology<\/span><\/em>\u00a033, 4105-4107, 1984.<\/li>\n<li>Del Zompo M et al. Peripheral benzodiazepine binding sites in kidney: modifications by diabetes insipidus.\u00a0<em><span style=\"text-decoration: underline;\">Life Sciences<\/span><\/em>\u00a035, 2095-2013, 1984 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6092814?ordinalpos=71&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Dopaminergic system and clincal aspects of depression.\u00a0<em><span style=\"text-decoration: underline;\">Clinical Neuropharmacology<\/span><\/em>\u00a07 (Suppl.1), 926-927, 1984.<\/li>\n<li>Del Zompo M et al. Linkage between X-chromosome markers and manic-depressive illness. Two Sardinian pedigrees.\u00a0<em><span style=\"text-decoration: underline;\">Acta Psychiatrica Scandinavica<\/span><\/em>\u00a070, 282-287, 1984 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6333780?ordinalpos=72&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Prophylactic efficacy of carbamazepine in lithium-resistant affective disorders. In: \u201cCurrent Trends in Lithium and Rubidium Therapy\u201d, Ed. G.U. Corsini, MTP Press Limited, Lancaster, UK, pp. 325-330, 1984.<\/li>\n<li>Del Zompo M et al. Lithium treatment in schizoaffective patients.\u00a0In: \u201cCurrent Trends in Lithium and Rubidium Therapy\u201d, Ed. G.U.Corsini, MTP Press, Limited, Lancaster, UK, pp. 142-150; 1984.<\/li>\n<li>Del Zompo M et al. Properties of benzodiazepine binding sites in peripheral tissues. In: \u201cBenzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology\u201d, Eds. G. Biggio and E. Costa, Raven Press, New York, pp. 239-248; 1983.<\/li>\n<li>Del Zompo M, Post R, Tallman JF. Properties of two benzodiazepine binding sites in spinal cord. <em><span style=\"text-decoration: underline;\">Neuropharmacology<\/span><\/em>\u00a022, 115-118, 1983 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6302542?ordinalpos=76&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Del Zompo M et al. Increased paroxysmal activity of partial seizures in man by apomorphine.\u00a0<em><span style=\"text-decoration: underline;\">Psychopharmacology<\/span><\/em>\u00a079, 209-214, 1983 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6405430?ordinalpos=74&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corsini GU et al. The use of dopamine agonists in the treatment of schizophrenia.\u00a0<em><span style=\"text-decoration: underline;\">Neuropharmacology<\/span><\/em>\u00a020: 1309-1313-1981.<\/li>\n<li>Del Zompo M et al. Antipsychotic effect of apomorphine: a retrospective study. In: \u201cApomorphine and Other Dopaminomimetics vol. 2, Clinical Pharmacology\u201d, Eds. G.U. Corsini and G.L. Gessa, Raven Press, New York, pp. 65-76; 1981.<\/li>\n<li>Corsini et al. Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson\u2019s disease.\u00a0<em><span style=\"text-decoration: underline;\">The Lancet<\/span><\/em>\u00a0i (8122), 954-956, 1979 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/87620?ordinalpos=79&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corsini GU et al. (-) Sulpiride as a specific antagonist of &#8220;low-dose&#8221; effects of apomorphine in man. In: \u201cSulpiride and Other Benzamides\u201d, Eds.\u00a0 P.F. Spano, M. Trabucchi, G.U. Corsini, G.L. Gessa, IBRF Press, Milano, pp. 255-267, 1979.<\/li>\n<li>Corsini GU et al. Parkinsonism by haloperidol and piribedil.\u00a0<em><span style=\"text-decoration: underline;\">Psychopharmacology<\/span><\/em>\u00a059, 139-141, 1978 [<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/103114?ordinalpos=80&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum\">abs<\/a>]<\/li>\n<li>Corsini GU et al. Evidence for dopamine receptors in the human brain mediating sedation and sleep.\u00a0<em><span style=\"text-decoration: underline;\">Life Sciences<\/span><\/em>\u00a020, 1613-1618, 1977.<\/li>\n<li>Corsini GU et al. Sedative, hypnotic and antipsychotic effects of low doses of apomorphine in man. In: \u201cAdvances in Biochemical Psychopharmacology\u201d, Eds. E. Costa and G.L. Gessa, Raven Press, New York, vol 16, pp 645-648, 1977.<\/li>\n<li>Corsini GU et al. Therapeutical efficacy of a combination of apomorphine with Sulpiride or Metoclopramide\u00a0 in Parkinsonism.\u00a0<em><span style=\"text-decoration: underline;\">Psychopharmacology<\/span><\/em>\u00a047, 169-173; 1976.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Viswanath\u00a0B et al. Cellular models to study bipolar disorder: A systematic review. J Affect Disord. 2015;\u00a0184:36-50 [abs] Costa M et al.\u00a0Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes.\u00a0J Mol Neurosci. 2015;\u00a056:688-95 [abs] Cadeddu G et al. \u00a0Clozapine toxicity due to a multiple drug interaction: &hellip; <a href=\"https:\/\/candidati.unica.it\/mariadelzompo\/profilo\/pubblicazioni-internazionali\/\" class=\"more-link\">Continua la lettura di <span class=\"screen-reader-text\">Pubblicazioni internazionali<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":241,"featured_media":0,"parent":451,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-76","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/pages\/76","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/users\/241"}],"replies":[{"embeddable":true,"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/comments?post=76"}],"version-history":[{"count":8,"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/pages\/76\/revisions"}],"predecessor-version":[{"id":565,"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/pages\/76\/revisions\/565"}],"up":[{"embeddable":true,"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/pages\/451"}],"wp:attachment":[{"href":"https:\/\/candidati.unica.it\/mariadelzompo\/wp-json\/wp\/v2\/media?parent=76"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}